Cofactor Genomics acquires Narus; ups focus on RNA diagnostics
In a move that will clearly up its focus on RNA diagnostics, St. Louis-based Cofactor Genomics has acquired San Francisco's Narus Biotechnologies.
In a move that will clearly up its focus on RNA diagnostics, St. Louis-based Cofactor Genomics has acquired San Francisco's Narus Biotechnologies.
Diagnostics could soon become a whole lot better, and people are investing in it. Heavily.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.